Microfluidic channel-coupled 3D quartz nanohole arrays for high capture and release efficiency of BT20 cancer cells

Jung Taek Lim, Yo Seop Yoon, Won Yong Lee, Jin Tak Jeong, Gil Sung Kim, Tae Geun Kim, Sang Kwon Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Nanostructured materials, such as silicon nanowires, quartz nanostructures, and polymer-modified nanostructures, are a promising new class of materials for the capture and enumeration of very rare tumor cells, including circulating tumor cells (CTCs), to examine their biological characteristics in whole blood of cancer patients. These cells can then be used for transplantation, anti-tumor cell therapy, and cell-secreted protein studies. It is believed that 3-dimensional (3D) nanostructured substrates efficiently enhance cell capture yields due to the increased local contacts between the 3D nanostructures and extracellular extensions of the tumor cells. Recent studies have been performed with enhanced cell capture yields thanks to various nanostructured platforms; however, there remains an urgent need both to capture and release viable rare tumor cells for further molecular (i.e., protein) analysis and to develop patient-specific drugs. Here, we first demonstrate that our 3D quartz nanohole array (QNHA) tumor cell capture and release system allows us not only to selectively capture rare tumor cells, but also to release the cells with high capture and release rates. This system was developed using streptavidin (STR)-functionalized QNHA (STR-QNHA) with a microfluidic channel. Our system has ideal cell-separation yields of as high as 85-91% and high release rates of >90% for the BT20 cell line. We suggest that the use of a microfluidic channel technique coupled with a STR-QNHA cell capture and release chip (STR-QNHA cell chip) would be a powerful and simple process to evaluate the capture, enumeration, and release of CTCs from patient whole blood for studying further cell therapy and tumor-cell-secreted molecules.

Original languageEnglish
Pages (from-to)17224-17232
Number of pages9
JournalNanoscale
Volume9
Issue number44
DOIs
Publication statusPublished - 2017 Nov 28

Fingerprint

Quartz
Microfluidics
Tumors
Cells
Streptavidin
Nanostructures
Blood
Proteins
Silicon
Nanostructured materials
Nanowires
Polymers
Molecules

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Microfluidic channel-coupled 3D quartz nanohole arrays for high capture and release efficiency of BT20 cancer cells. / Lim, Jung Taek; Yoon, Yo Seop; Lee, Won Yong; Jeong, Jin Tak; Kim, Gil Sung; Kim, Tae Geun; Lee, Sang Kwon.

In: Nanoscale, Vol. 9, No. 44, 28.11.2017, p. 17224-17232.

Research output: Contribution to journalArticle

Lim, Jung Taek ; Yoon, Yo Seop ; Lee, Won Yong ; Jeong, Jin Tak ; Kim, Gil Sung ; Kim, Tae Geun ; Lee, Sang Kwon. / Microfluidic channel-coupled 3D quartz nanohole arrays for high capture and release efficiency of BT20 cancer cells. In: Nanoscale. 2017 ; Vol. 9, No. 44. pp. 17224-17232.
@article{61695c13a6fc4f29b2a111828ad5ecc2,
title = "Microfluidic channel-coupled 3D quartz nanohole arrays for high capture and release efficiency of BT20 cancer cells",
abstract = "Nanostructured materials, such as silicon nanowires, quartz nanostructures, and polymer-modified nanostructures, are a promising new class of materials for the capture and enumeration of very rare tumor cells, including circulating tumor cells (CTCs), to examine their biological characteristics in whole blood of cancer patients. These cells can then be used for transplantation, anti-tumor cell therapy, and cell-secreted protein studies. It is believed that 3-dimensional (3D) nanostructured substrates efficiently enhance cell capture yields due to the increased local contacts between the 3D nanostructures and extracellular extensions of the tumor cells. Recent studies have been performed with enhanced cell capture yields thanks to various nanostructured platforms; however, there remains an urgent need both to capture and release viable rare tumor cells for further molecular (i.e., protein) analysis and to develop patient-specific drugs. Here, we first demonstrate that our 3D quartz nanohole array (QNHA) tumor cell capture and release system allows us not only to selectively capture rare tumor cells, but also to release the cells with high capture and release rates. This system was developed using streptavidin (STR)-functionalized QNHA (STR-QNHA) with a microfluidic channel. Our system has ideal cell-separation yields of as high as 85-91{\%} and high release rates of >90{\%} for the BT20 cell line. We suggest that the use of a microfluidic channel technique coupled with a STR-QNHA cell capture and release chip (STR-QNHA cell chip) would be a powerful and simple process to evaluate the capture, enumeration, and release of CTCs from patient whole blood for studying further cell therapy and tumor-cell-secreted molecules.",
author = "Lim, {Jung Taek} and Yoon, {Yo Seop} and Lee, {Won Yong} and Jeong, {Jin Tak} and Kim, {Gil Sung} and Kim, {Tae Geun} and Lee, {Sang Kwon}",
year = "2017",
month = "11",
day = "28",
doi = "10.1039/c7nr04961g",
language = "English",
volume = "9",
pages = "17224--17232",
journal = "Nanoscale",
issn = "2040-3364",
publisher = "Royal Society of Chemistry",
number = "44",

}

TY - JOUR

T1 - Microfluidic channel-coupled 3D quartz nanohole arrays for high capture and release efficiency of BT20 cancer cells

AU - Lim, Jung Taek

AU - Yoon, Yo Seop

AU - Lee, Won Yong

AU - Jeong, Jin Tak

AU - Kim, Gil Sung

AU - Kim, Tae Geun

AU - Lee, Sang Kwon

PY - 2017/11/28

Y1 - 2017/11/28

N2 - Nanostructured materials, such as silicon nanowires, quartz nanostructures, and polymer-modified nanostructures, are a promising new class of materials for the capture and enumeration of very rare tumor cells, including circulating tumor cells (CTCs), to examine their biological characteristics in whole blood of cancer patients. These cells can then be used for transplantation, anti-tumor cell therapy, and cell-secreted protein studies. It is believed that 3-dimensional (3D) nanostructured substrates efficiently enhance cell capture yields due to the increased local contacts between the 3D nanostructures and extracellular extensions of the tumor cells. Recent studies have been performed with enhanced cell capture yields thanks to various nanostructured platforms; however, there remains an urgent need both to capture and release viable rare tumor cells for further molecular (i.e., protein) analysis and to develop patient-specific drugs. Here, we first demonstrate that our 3D quartz nanohole array (QNHA) tumor cell capture and release system allows us not only to selectively capture rare tumor cells, but also to release the cells with high capture and release rates. This system was developed using streptavidin (STR)-functionalized QNHA (STR-QNHA) with a microfluidic channel. Our system has ideal cell-separation yields of as high as 85-91% and high release rates of >90% for the BT20 cell line. We suggest that the use of a microfluidic channel technique coupled with a STR-QNHA cell capture and release chip (STR-QNHA cell chip) would be a powerful and simple process to evaluate the capture, enumeration, and release of CTCs from patient whole blood for studying further cell therapy and tumor-cell-secreted molecules.

AB - Nanostructured materials, such as silicon nanowires, quartz nanostructures, and polymer-modified nanostructures, are a promising new class of materials for the capture and enumeration of very rare tumor cells, including circulating tumor cells (CTCs), to examine their biological characteristics in whole blood of cancer patients. These cells can then be used for transplantation, anti-tumor cell therapy, and cell-secreted protein studies. It is believed that 3-dimensional (3D) nanostructured substrates efficiently enhance cell capture yields due to the increased local contacts between the 3D nanostructures and extracellular extensions of the tumor cells. Recent studies have been performed with enhanced cell capture yields thanks to various nanostructured platforms; however, there remains an urgent need both to capture and release viable rare tumor cells for further molecular (i.e., protein) analysis and to develop patient-specific drugs. Here, we first demonstrate that our 3D quartz nanohole array (QNHA) tumor cell capture and release system allows us not only to selectively capture rare tumor cells, but also to release the cells with high capture and release rates. This system was developed using streptavidin (STR)-functionalized QNHA (STR-QNHA) with a microfluidic channel. Our system has ideal cell-separation yields of as high as 85-91% and high release rates of >90% for the BT20 cell line. We suggest that the use of a microfluidic channel technique coupled with a STR-QNHA cell capture and release chip (STR-QNHA cell chip) would be a powerful and simple process to evaluate the capture, enumeration, and release of CTCs from patient whole blood for studying further cell therapy and tumor-cell-secreted molecules.

UR - http://www.scopus.com/inward/record.url?scp=85034649133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034649133&partnerID=8YFLogxK

U2 - 10.1039/c7nr04961g

DO - 10.1039/c7nr04961g

M3 - Article

C2 - 29068023

AN - SCOPUS:85034649133

VL - 9

SP - 17224

EP - 17232

JO - Nanoscale

JF - Nanoscale

SN - 2040-3364

IS - 44

ER -